INAB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

IN8bio Insider Trading History Chart

IN8bio Share Price & Price History

^$1.42

▼ -0.08 (-5.33%)

As of 12/17/2025 05:00 PM ET

Days: 30 | 90 | 365

IN8bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/13/2023	Jeremy R Graff	Director	Buy	83	$28.50	$2,365.50	83
8/25/2023	Patrick Mccall	CFO	Buy	33	$30.90	$1,019.70	208
8/24/2023	William Tai-Wei Ho	CEO	Buy	793	$31.50	$24,979.50	77,984

SEC Filings (Institutional Ownership Changes) for IN8bio (NASDAQ:INAB)

92.05% of IN8bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

IN8bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2025	Citadel Advisors LLC	24,728	$54K	0.0%	N/A	0.586%
11/14/2025	Two Sigma Investments LP	49,453	$0.11M	0.0%	N/A	1.172%
8/13/2025	Stonepine Capital Management LLC	82,430	$0.17M	0.2%	N/A	2.720%
8/12/2025	BIOS Capital Management LP	286,664	$0.60M	0.8%	-96.7%	9.461%
8/12/2025	Franklin Resources Inc.	189,894	$0.40M	0.0%	-96.7%	6.267%
8/8/2025	Geode Capital Management LLC	18,820	$39K	0.0%	-96.7%	0.622%
7/29/2025	AIGH Capital Management LLC	149,895	$0.31M	0.1%	-89.7%	4.947%
5/16/2025	Alyeska Investment Group L.P.	2,079,575	$0.35M	0.0%	-58.9%	2.291%
5/6/2025	AIGH Capital Management LLC	1,450,000	$0.24M	0.1%	-76.6%	1.784%
5/2/2025	Sigma Planning Corp	700,680	$0.12M	0.0%	-32.7%	0.862%
2/18/2025	BIOS Capital Management LP	8,600,001	$2.21M	2.4%	N/A	11.865%
2/17/2025	Alyeska Investment Group L.P.	5,063,291	$1.30M	0.0%	+1,064.5%	6.986%
2/17/2025	683 Capital Management LLC	750,000	$0.19M	0.0%	-44.5%	1.035%
2/14/2025	Jane Street Group LLC	115,919	$30K	0.0%	+296.7%	0.160%
2/12/2025	Geode Capital Management LLC	515,193	$0.13M	0.0%	+56.5%	0.711%
2/12/2025	Franklin Resources Inc.	5,696,202	$1.47M	0.0%	N/A	7.859%
2/12/2025	AIGH Capital Management LLC	6,191,865	$1.59M	0.5%	+269.7%	8.543%
2/10/2025	BIOS Capital Management LP	8,600,001	$2.21M	2.3%	N/A	11.865%
2/3/2025	Sigma Planning Corp	1,041,380	$0.27M	0.0%	+22.3%	1.437%
11/4/2024	Sigma Planning Corp	851,280	$0.23M	0.0%	+42.0%	1.819%
8/7/2024	AIGH Capital Management LLC	2,127,998	$1.80M	0.6%	-26.0%	4.823%
2/12/2024	AIGH Capital Management LLC	4,098,361	$5.22M	2.1%	N/A	12.811%
2/8/2024	Texas Capital Bank Wealth Management Services Inc	78,624	$0.11M	0.0%	+85.2%	0.246%
2/1/2024	Sigma Planning Corp	132,230	$0.18M	0.0%	-53.6%	0.413%
1/30/2024	Voss Capital LLC	341,209	$0.47M	0.0%	-33.3%	1.067%
11/13/2023	Rock Creek Group LP	151,314	$0.16M	0.0%	+98.3%	0.473%
10/19/2023	Voss Capital LLC	511,584	$0.53M	0.1%	+11.7%	1.619%
8/11/2023	Overbrook Management Corp	33,756	$52K	0.0%	N/A	0.113%
8/2/2023	Sigma Planning Corp	279,400	$0.43M	0.0%	+37.0%	0.939%
7/28/2023	Voss Capital LLC	457,876	$0.71M	0.1%	+35.5%	1.539%
5/8/2023	Sigma Planning Corp	203,900	$0.27M	0.0%	+105.6%	0.816%
2/13/2023	Voss Capital LLC	338,019	$0.78M	0.2%	-10.0%	1.380%
11/15/2022	Precept Management LLC	50,000	$0.10M	0.7%	N/A	0.204%
11/7/2022	Warberg Asset Management LLC	15,000	$30K	0.0%	N/A	0.080%
11/2/2022	Voss Capital LLC	375,570	$0.76M	0.2%	-25.7%	1.993%
10/28/2022	Stonegate Investment Group LLC	232,310	$0.47M	0.0%	-12.8%	1.233%
10/24/2022	United Asset Strategies Inc.	14,000	$28K	0.0%	N/A	0.074%
8/15/2022	Nantahala Capital Management LLC	148,801	$0.36M	0.0%	-57.8%	0.790%
8/13/2022	Voss Capital LLC	505,635	$1.14M	0.4%	+95.2%	2.684%
8/9/2022	Stonegate Investment Group LLC	266,500	$0.60M	0.0%	N/A	1.415%
5/11/2022	Rock Creek Group LP	86,032	$0.30M	0.0%	+87.5%	0.457%
4/20/2022	Sigma Planning Corp	97,750	$0.33M	0.0%	+241.8%	0.520%
2/11/2022	Ensign Peak Advisors Inc	70,028	$0.31M	0.0%	N/A	0.373%
2/10/2022	HighTower Advisors LLC	10,000	$44K	0.0%	N/A	0.053%
2/2/2022	Sigma Planning Corp	28,600	$0.13M	0.0%	N/A	0.153%
11/16/2021	Voss Capital LLC	80,727	$0.56M	0.2%	N/A	0.430%
11/16/2021	Capital World Investors	800,000	$5.52M	0.0%	N/A	4.266%
11/15/2021	Tudor Investment Corp Et Al	63,287	$0.43M	0.0%	N/A	0.337%
11/10/2021	B. Riley Financial Inc.	257,378	$1.76M	0.2%	N/A	1.372%

Data available starting January 2016

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidates include INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation; and INB-400, which is in Phase 2 clinical trial to treat newly diagnosed GBM. It also develops INB-300, INB-410, and INB-500 that are in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Today's Range

Now: $1.42

$1.38

$1.50

50 Day Range

MA: $1.85

$1.42

$2.33

52 Week Range

Now: $1.42

$1.38

$12.53

Volume

50,932 shs

Average Volume

52,124 shs

Market Capitalization

$5.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.02

Who are the major institutional investors of IN8bio?: IN8bio's top institutional shareholders include:
Two Sigma Investments LP — 1.17%
Citadel Advisors LLC — 0.59%
Learn More about top institutional investors of IN8bio stock.
Which major investors are buying IN8bio stock?: In the previous quarter, INAB stock was bought by institutional investors including:
Two Sigma Investments LP
Citadel Advisors LLC